Karuna Therapeutics soars on potentially 'game changing' new schizophrenia drug

Karuna CEO Dr. Steve Paul and CNBC's Meg Tirrell discuss Karuna Therapeutics' new schizophrenia drug, which is said to be a 'game-changer.'
03:42
Fri, Nov 22 20193:40 PM EST